TNFR2 signaling promotes monocytic-MDSC differentiation and production of immunosuppressive mediators

Yuta Tsuji1, Masaki Inoue1, Tomoya Okuda1

  • 1The Faculty of Pharmaceutical Sciences, Laboratory of Cellular and Molecular Physiology, Kobe Gakuin University, Japan.

FEBS Letters
|February 25, 2026
PubMed

Insights

Tumor-promoting myeloid-derived suppressor cells (MDSCs) rely on TNF receptor type 2 (TNFR2) signaling. Targeting TNFR2 can modulate MDSC function and potentially enhance cancer therapy by reducing immunosuppression.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cell Signaling

Background:

  • Myeloid-derived suppressor cells (MDSCs) are key regulators of the tumor microenvironment, promoting cancer progression and therapeutic resistance.
  • MDSCs express high levels of TNF receptor type 2 (TNFR2), but its specific function is obscured by the dual action of TNF-α on TNFR1 and TNFR2.

Purpose of the Study:

  • To investigate the specific role of TNFR2 signaling in the function and differentiation of MDSCs.
  • To evaluate TNFR2 as a potential therapeutic target for modulating MDSC-mediated immunosuppression in cancer.

Main Methods:

  • Utilized TNFR2-knockout mice to generate GM-CSF-induced MDSCs.
  • Employed a TNFR2-selective agonist (scR2agoTNF-Fc) to stimulate MDSCs.
  • Assessed the impact of TNFR2 modulation on MDSC suppressive capacity and effector molecule expression.

Main Results:

  • TNFR2 activation maintained a highly suppressive monocytic MDSC subset.
  • TNFR2 deficiency significantly reduced MDSC-mediated suppression of T-cell responses.
  • TNFR2 signaling upregulated key immunosuppressive molecules, including inducible nitric-oxide synthase (iNOS) and interleukin-10 (IL-10).

Conclusions:

  • TNFR2 plays a critical role in maintaining the immunosuppressive functions of MDSCs.
  • Targeting TNFR2 represents a promising therapeutic strategy to counteract MDSC-driven immune suppression in cancer.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.8K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.1K